Investors who 'sell in May and go away' this year could miss a big summer rally in the stock market, Bank of America says
references the fact that the stock market has historically performed weak during the six-month period of May through October.
The fact that the average and median gains for the stock market are not negative during the"sell in May and go away" time frame, the strategy"leaves much to be desired," Suttmeier said. "May can be a weak month for the S&P 500, but if you 'sell in May and go away' you could miss a Summer rally," Suttmeier said.
That contrasts with the months of May and September, which have delivered average returns of -0.04% and -1.16%, respectively.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
JNJ Stock Price | Johnson & Johnson Stock - Investing.comGet today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more.
Consulte Mais informação »
XPeng stock jumps after new production platform unveiled, Nio and Li Auto shares also rallyThe U.S.-listed shares of XPeng Inc. charged up 11.3% in premarket trading Monday, after the China-based electric vehicle (EV) maker unveiled a new...
Consulte Mais informação »
Stock market outlook: Rally coming amid strong earnings, weaker dollarThe stock market is poised to rally thanks to strong earnings and a weakening dollar, Deutsche Bank's chief US equity strategist says
Consulte Mais informação »
Nvidia’s stock could keep riding the AI wave despite huge rally, analyst saysNvidia Corp.'s potential in artificial intelligence continues to help win over those who were formerly skeptical about the shares.
Consulte Mais informação »
U.S. stock futures near highs of the year as earnings season eyedThe S&P 500 is in line to begin Monday near the top of the 3,800 to 4,200 range within which it has vacillated for about five months.
Consulte Mais informação »
Amneal Pharmaceuticals’ stock soars 14% premarket after company offers upbeat Q1 guidanceAmneal Pharmaceuticals Inc.’s stock soared 14% in premarket trade Monday, after the generics and specialty pharmaceuticals company offered first-quarter...
Consulte Mais informação »